KLOW
On NovaEvumFull protocol
1–2.5 mg GHK-Cu daily (blend)
Reconstitution
| Vial | 3 mL water | 4 mL water | 5 mL water |
|---|---|---|---|
| 80 mg | 26.67 mg/mL | 20 mg/mL | 16 mg/mL |
KLOW is a blend (GHK-Cu, BPC-157, TB-500, KPV in a 5:1:1:1 ratio), so 80 mg is the combined weight. The NovaEvum worksheet uses 4 mL (20 mg/mL total). More water dilutes the GHK-Cu sting. The calculator works in total blend mg: since GHK-Cu is 5 of every 8 parts, 1.25 mg of GHK-Cu is 2 mg of total blend.
- Use bacteriostatic water as the diluent.
- Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
- Swirl gently to mix, then leave it to dissolve. Do not shake.
- Give it a few minutes. The finished solution should be clear and colourless.
- A faint blue tint from the copper is normal.
- The solution should otherwise be clear once mixed.
Protocol
Route: Subcutaneous
How a blend is dosed
- Like GLOW, dose KLOW by the GHK-Cu amount; the BPC-157, TB-500 and KPV follow in the 5:1:1:1 ratio
- The common range is 1 mg to 2.5 mg of GHK-Cu per day. Start around 1.25 mg and move toward 2.5 mg during loading if tolerated
- At a 4 mL fill the GHK-Cu portion comes to 12.5 mg/mL, so 1.25 mg of GHK-Cu (2 mg of blend) is a 0.1 mL draw (10 units) and 2.5 mg is 0.2 mL (20 units)
- These figures are for a 4 mL fill; with any other fill, recalculate the draws
Schedule
- One subcutaneous injection daily, or 5 days on, 2 days off, rotating sites
- Run an 8 to 12 week block, then 4 to 8 weeks off
- Inject slowly to limit the GHK-Cu sting
- KLOW adds KPV, so it leans more anti-inflammatory than GLOW
Dosing detail
- Dose by GHK-Cu content, 1 mg to 2.5 mg daily, scaling the rest of the blend with it. Around 2.5 mg is common during loading.
- Once daily, subcutaneous, sites rotated.
- Inject slowly given the copper content.
Duration
- Typically run 8 to 12 weeks, often 5 days on and 2 off (or daily loading then 3 times weekly), then 4 to 8 weeks off and reassess.
Notes
- Adds KPV (an anti-inflammatory tripeptide) to the GLOW base of GHK-Cu, BPC-157 and TB-500.
- Inject subcutaneously and rotate sites.
- Inject slowly given the copper content.
Storage and handling
- Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
- Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 28 days.
- Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
- If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.
- A faint blue tint is normal because of the GHK-Cu in the blend, not a sign of degradation.
NovaEvum vial
Worksheet
4 mL bacteriostatic water yields 20 mg/mL total. A 0.1 mL (10 unit) draw is 2 mg total peptide: 1.25 mg GHK-Cu and 0.25 mg of each of the other three.
- Catalog fill
- 80 mg blend
- Typical water
- 4 mL
- Route
- Subcutaneous
- Cycle
- 8–12 weeks, then 4–8 weeks off.
| Step | Amount | Frequency | Notes |
|---|---|---|---|
| Daily research draw | 2 mg total | Once daily | 10 units from a 4 mL reconstitution |
| Smaller daily draw | 1 mg total | Once daily | 5 units |
- The certificate of analysis is the record of the actual fill. This worksheet uses the labelled split.
- Do not add extra BPC-157, TB-500, KPV, or GHK-Cu on top without subtracting what KLOW already contributes.
- Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
- Amounts on this sheet are reconstitution math for the vial, not a recommendation.